4 results
The objective of this study is to explore the efficacy and safety of gevokizumab in patients with Schnitzler syndrome.
The primary objective of this study is to further evaluate the safety and tolerability of pegaptanib sodium in subjects with DME.
The objective of this study is to evaluate the effect of the 4 successive monthly subcutaneous administrations of 30 mg of gevokizumab (in part A) , as well as 60mg (in part B) of the protocol, versus placebo on the reduction of arterial wall…
Primary Objective: The aim of the study is to show that STEMI patients who are pre-treated with crushed ticagrelor and paracetamol have a higher level of platelet inhibition after primary PCI than patients pre-treated with crushed ticagrelor who are…